ACE2 and Microbiota: Emerging Targets for Cardiopulmonary Disease Therapy
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
The health of the cardiovascular and pulmonary systems is inextricably linked to the renin-angiotensin system (RAS). Physiologically speaking, a balance between the vasodeleterious (Angiotensin-converting enzyme [ACE]/Angiotensin II [Ang II]/Ang II type 1 receptor [AT1R]) and vasoprotective (Angiotensin-converting enzyme 2 [ACE2]/Angiotensin-(1-7) [Ang-(1-7)]/Mas receptor [MasR]) components of the RAS is critical for cardiopulmonary homeostasis. Upregulation of the ACE/Ang II/AT1R axis shifts the system toward vasoconstriction, proliferation, hypertrophy, inflammation, and fibrosis, all factors that contribute to the development and progression of cardiopulmonary diseases. Conversely, stimulation of the vasoprotective ACE2/Ang-(1-7)/MasR axis produces a counter-regulatory response that promotes cardiovascular health. Current research is investigating novel strategies to augment actions of the vasoprotective RAS components, particularly ACE2, in order to treat various pathologies. Although multiple approaches to increase the activity of ACE2 have displayed beneficial effects against experimental disease models, the mechanisms behind its protective actions remain incompletely understood. Recent work demonstrating a non-catalytic role for ACE2 in amino acid transport in the gut has led us to speculate that the therapeutic effects of ACE2 can be mediated, in part, by its actions on the gastrointestinal tract and/or gut microbiome. This is consistent with emerging data which suggest that dysbiosis of the gut and lung microbiomes is associated with cardiopulmonary disease. This review highlights new developments in the protective actions of ACE2 against cardiopulmonary disorders, discusses innovative approaches to targeting ACE2 for therapy, and explores an evolving role for gut and lung microbiota in cardiopulmonary health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923
Heart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., de Ferranti, S., Després, J.-P., Fullerton, H. J., Howard, V. J., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000152 · Cited by 5,797
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
Mehta, P. K., & Griendling, K. K. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00287.2006 · Cited by 1,924
Physiology of Local Renin-Angiotensin Systems
Paul, M., Poyan Mehr, A., & Kreutz, R. (2006) · Physiological Reviews · doi:10.1152/physrev.00036.2005 · Cited by 1,739
Angiotensin-converting enzyme 2 is an essential regulator of heart function
Crackower, M. A., Sarao, R., Oudit, G. Y., Yagil, C., Kozieradzki, I., Scanga, S. E., Oliveira-dos-Santos, A. J., da Costa, J., Zhang, L., Pei, Y., et al. (2002) · Nature · doi:10.1038/nature00786 · Cited by 1,733
Gut Dysbiosis Is Linked to Hypertension
Yang, T., Santisteban, M. M., Rodriguez, V., Li, E., Ahmari, N., Carvajal, J. M., Zadeh, M., Gong, M., Qi, Y., Zubcevic, J., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05315 · Cited by 1,478
Self-citationACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation
Hashimoto, T., Perlot, T., Rehman, A., Trichereau, J., Ishiguro, H., Paolino, M., Sigl, V., Hanada, T., Hanada, R., Lipinski, S., et al. (2012) · Nature · doi:10.1038/nature11228 · Cited by 1,271
Human oral, gut, and plaque microbiota in patients with atherosclerosis
Koren, O., Spor, A., Felin, J., Fåk, F., Stombaugh, J., Tremaroli, V., Behre, C. J., Knight, R., Fagerberg, B., Ley, R. E., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011383107 · Cited by 1,196
Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme
Harmer, D., Gilbert, M., Borman, R., & Clark, K. L. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03640-2 · Cited by 852
Ait-Belgnaoui, A., Durand, H., Cartier, C., Chaumaz, G., Eutamene, H., Ferrier, L., Houdeau, E., Fioramonti, J., Bueno, L., & Theodorou, V. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.03.024 · Cited by 612
Research works printed but not linked: 132
- Hall, 2003, Historical perspective of the renin-angiotensin system., Mol Biotechnol, 24, 27, 10.1385/MB:24:1:27 · DOI
- Fliser, 2004, Haller H; EUropean Trial on Olmesartan and Pravastatin in Inflammation and Atherosclerosis (EUTOPIA) Investigators. Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation., Circulation, 110, 1103, 10.1161/01.CIR.0000140265.21608.8E · DOI · Paper page
- Ferrario, 2006, Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease., Am J Cardiol, 98, 121, 10.1016/j.amjcard.2006.01.059 · DOI · Paper page
- van Vark, 2012, . Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158,998 patients., Eur Heart J, 33, 2088, 10.1093/eurheartj/ehs075 · DOI · Paper page
- 2013, MEMBERS, Yancy CW, Jessup M, et al.. 2013 ACCFAHA guideline for the management of heart failure: a report of the American College of Cardiology FoundationAmerican Heart Association task force on practice guidelines., Circulation, 128, e240
- Gavras, 1978, . Antihypertensive effect of the oral angiotensin converting-enzyme inhibitor SQ 14225 in man., N Engl J Med, 298, 991, 10.1056/NEJM197805042981803 · DOI · Paper page
- Konstam, 1995, Angiotensin converting enzyme inhibition in asymptomatic left ventricular systolic dysfunction and early heart failure., Eur Heart J, 16, 59, 10.1093/eurheartj/16.suppl_N.59 · doi:10.1093/eurheartj/16.suppl_n.59
- Donoghue, 2000, . A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9., Circ Res, 87, E1, 10.1161/01.RES.87.5.e1 · DOI · Paper page
- Tipnis, 2000, . A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase., J Biol Chem, 275, 33238, 10.1074/jbc.M002615200 · DOI · Paper page
- Tallant, 2005, Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor., Am J Physiol Heart Circ Physiol, 289, H1560, 10.1152/ajpheart.00941.2004 · DOI · Paper page
- Grobe, 2006, . Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension., Am J Physiol Heart Circ Physiol, 290, H2417, 10.1152/ajpheart.01170.2005 · DOI · Paper page
- Qi, 2011, . Lentivirus-mediated overexpression of angiotensin-(1-7) attenuated ischaemia-induced cardiac pathophysiology., Exp Physiol, 96, 863, 10.1113/expphysiol.2011.056994 · DOI
- Der Sarkissian, 2008, . Cardiac overexpression of angiotensin converting enzyme 2 protects the heart from ischemia-induced pathophysiology., Hypertension, 51, 712, 10.1161/HYPERTENSIONAHA.107.100693 · DOI · Paper page
- Shenoy, 2010, . The angiotensin-converting enzyme 2angiogenesis-(1-7)mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension., Am J Respir Crit Care Med, 182, 1065, 10.1164/rccm.200912-1840OC · DOI · Paper page
- Grobe, 2007, . Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7)., Am J Physiol Heart Circ Physiol, 292, H736, 10.1152/ajpheart.00937.2006 · DOI · Paper page
- Hernandez Prada, 2008, . Structure-based identification of small-molecule angiotensin-converting enzyme 2 activators as novel antihypertensive agents., Hypertension, 51, 1312, 10.1161/HYPERTENSIONAHA.107.108944 · DOI · Paper page
- Loot, 2002, . Angiotensin-(1-7) attenuates the development of heart failure after myocardial infarction in rats., Circulation, 105, 1548, 10.1161/01.CIR.0000013847.07035.B9 · DOI · Paper page
- Rodgers, 2003, . Histological evaluation of the effects of angiotensin peptides on wound repair in diabetic mice., Exp Dermatol, 12, 784, 10.1111/j.0906-6705.2003.00087.x · DOI · Paper page
- Oudit, 2010, . Human recombinant ACE2 reduces the progression of diabetic nephropathy., Diabetes, 59, 529, 10.2337/db09-1218 · DOI · Paper page
- Jarajapu, 2013, . Activation of the ACE2angiotensin-(1-7)mas receptor axis enhances the reparative function of dysfunctional diabetic endothelial progenitors., Diabetes, 62, 1258, 10.2337/db12-0808 · DOI
- Chen, 2013, . Angiotensin-converting enzyme 2 priming enhances the function of endothelial progenitor cells and their therapeutic efficacy., Hypertension, 61, 681, 10.1161/HYPERTENSIONAHA.111.00202 · DOI
- Yamazato, 2011, . Gene transfer of angiotensin-converting enzyme 2 in the nucleus tractus solitarius improves baroreceptor heart rate reflex in spontaneously hypertensive rats., J Renin Angiotensin Aldosterone Syst, 12, 456, 10.1177/1470320311412809 · DOI
- Xiao, 2011, . Brain-selective overexpression of angiotensin-converting enzyme 2 attenuates sympathetic nerve activity and enhances baroreflex function in chronic heart failure., Hypertension, 58, 1057, 10.1161/HYPERTENSIONAHA.111.176636 · DOI · Paper page
- Yamazato, 2007, . Overexpression of angiotensin-converting enzyme 2 in the rostral ventrolateral medulla causes long-term decrease in blood pressure in the spontaneously hypertensive rats., Hypertension, 49, 926, 10.1161/01.HYP.0000259942.38108.20 · DOI · Paper page
- Lu, 2012, . ACE2 gene polymorphism and essential hypertension: an updated meta-analysis involving 11,051 subjects., Mol Biol Rep, 39, 6581, 10.1007/s11033-012-1487-1 · DOI
- Patel, 2012, . Association of ACE2 genetic variants with blood pressure, left ventricular mass, and cardiac function in caucasians with type 2 diabetes., Am J Hypertens, 25, 216, 10.1038/ajh.2011.188 · DOI
- Lieb, 2006, . Association of angiotensin-converting enzyme 2 (ACE2) gene polymorphisms with parameters of left ventricular hypertrophy in men. results of the MONICA augsburg echocardiographic substudy., J Mol Med (Berl), 84, 88, 10.1007/s00109-005-0718-5 · DOI
- van der Merwe, 2008, . Genetic variation in angiotensin-converting enzyme 2 gene is associated with extent of left ventricular hypertrophy in hypertrophic cardiomyopathy., Hum Genet, 124, 57, 10.1007/s00439-008-0524-6 · doi:10.1007/s00439-008-0524-6
- Burrell, 2013, . The ACE2 gene: Its potential as a functional candidate for cardiovascular disease., Clin Sci (Lond), 124, 65, 10.1042/CS20120269 · DOI
- Yamamoto, 2006, . Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II., Hypertension, 47, 718, 10.1161/01.HYP.0000205833.89478.5b · DOI · Paper page
- Bodiga, 2011, . Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunit., Cardiovasc Res, 91, 151, 10.1093/cvr/cvr036 · DOI · Paper page
- Trask, 2010, . Inhibition of angiotensin-converting enzyme 2 exacerbates cardiac hypertrophy and fibrosis in ren-2 hypertensive rats., Am J Hypertens, 23, 687, 10.1038/ajh.2010.51 · DOI
- Huentelman, 2005, . Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats., Exp Physiol, 90, 783, 10.1113/expphysiol.2005.031096 · DOI · Paper page
- Johnson, 2011, . ACE2 improves right ventricular function in a pressure overload model., PLoS One, 6, e20828, 10.1371/journal.pone.0020828 · DOI
- Zhao, 2010, . ACE2 overexpression ameliorates left ventricular remodeling and dysfunction in a rat model of myocardial infarction., Hum Gene Ther, 21, 1545, 10.1089/hum.2009.160 · DOI
- Dong, 2012, . Angiotensin-converting enzyme-2 overexpression improves left ventricular remodeling and function in a rat model of diabetic cardiomyopathy., J Am Coll Cardiol, 59, 739, 10.1016/j.jacc.2011.09.071 · DOI
- Cohen-Segev, 2014, . Cardiac and renal distribution of ACE and ACE-2 in rats with heart failure., Acta Histochem, 116, 1342, 10.1016/j.acthis.2014.08.006 · DOI
- Zisman, 2003, . Increased angiotensin-(1-7)-forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin-converting enzyme homologue ACE2., Circulation, 108, 1707, 10.1161/01.CIR.0000094734.67990.99 · DOI · Paper page
- Goulter, 2004, . ACE2 gene expression is up-regulated in the human failing heart., BMC Med, 2, 19, 10.1186/1741-7015-2-19 · DOI · Paper page
- Kittleson, 2005, . Gene expression analysis of ischemic and nonischemic cardiomyopathy: shared and distinct genes in the development of heart failure., Physiol Genomics, 21, 299, 10.1152/physiolgenomics.00255.2004 · DOI · Paper page
- Batlle, 2006, . Increased expression of the renin-angiotensin system and mast cell density but not of angiotensin-converting enzyme II in late stages of human heart failure., J Heart Lung Transpl, 25, 1117, 10.1016/j.healun.2006.04.012 · DOI
- Ohtsuki, 2010, . Angiotensin converting enzyme 2 gene expression increased compensatory for left ventricular remodeling in patients with end-stage heart failure., Int J Cardiol, 145, 333, 10.1016/j.ijcard.2009.11.057 · DOI
- Epelman, 2008, . Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system., J Am Coll Cardiol, 52, 750, 10.1016/j.jacc.2008.02.088 · DOI · Paper page
- Epelman, 2009, . Soluble angiotensin-converting enzyme 2 in human heart failure: relation with myocardial function and clinical outcomes., J Card Fail, 15, 565, 10.1016/j.cardfail.2009.01.014 · DOI · Paper page
- Wang, 2010, . Plasma ACE2 activity is an independent prognostic marker in chagas disease and equally potent as BNP., J Card Fail, 16, 157, 10.1016/j.cardfail.2009.09.005 · DOI
- Ortiz-Perez, 2013, . Role of circulating angiotensin converting enzyme 2 in left ventricular remodeling following myocardial infarction: a prospective controlled study., PLoS One, 8, e61695, 10.1371/journal.pone.0061695 · DOI
- Uri, 2014, . New perspectives in the renin-angiotensin-aldosterone system (RAAS) IV: circulating ACE2 as a biomarker of systolic dysfunction in human hypertension and heart failure., PLoS One, 9, e87845, 10.1371/journal.pone.0087845 · DOI
- Shao, 2013, . Increasing serum soluble angiotensin-converting enzyme 2 activity after intensive medical therapy is associated with better prognosis in acute decompensated heart failure., J Card Fail, 19, 605, 10.1016/j.cardfail.2013.06.296 · DOI
- Feng, 2010, . Brain-selective overexpression of human angiotensin-converting enzyme type 2 attenuates neurogenic hypertension., Circ Res, 106, 373, 10.1161/CIRCRESAHA.109.208645 · DOI · Paper page
- Xia, 2008, Angiotensin-converting enzyme 2 in the brain: properties and future directions., J Neurochem, 107, 1482, 10.1111/j.1471-4159.2008.05723.x · DOI · Paper page
- Feng, 2008, . Angiotensin-converting enzyme 2 overexpression in the subfornical organ prevents the angiotensin II-mediated pressor and drinking responses and is associated with angiotensin II type 1 receptor downregulation., Circ Res, 102, 729, 10.1161/CIRCRESAHA.107.169110 · DOI · Paper page
- Sriramula, 2011, . ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension., Cardiovasc Res, 92, 401, 10.1093/cvr/cvr242 · DOI · Paper page
- Xia, 2011, . ACE2-mediated reduction of oxidative stress in the central nervous system is associated with improvement of autonomic function., PLoS One, 6, e22682, 10.1371/journal.pone.0022682 · DOI
- Jun, 2012, . Brain-mediated dysregulation of the bone marrow activity in angiotensin II-induced hypertension., Hypertension, 60, 1316, 10.1161/HYPERTENSIONAHA.112.199547 · DOI · Paper page
- Zhang, 2014, Endothelial progenitor cells and vascular repair., Curr Opin Hematol, 21, 224, 10.1097/MOH.0000000000000041 · DOI · Paper page
- Valgimigli, 2004, . CD34 and endothelial progenitor cells in patients with various degrees of congestive heart failure., Circulation, 110, 1209, 10.1161/01.CIR.0000136813.89036.21 · DOI · Paper page
- Fritzenwanger, 2009, . Differential number of CD34, CD133 and CD34CD133 cells in peripheral blood of patients with congestive heart failure., Eur J Med Res, 14, 113, 10.1186/2047-783X-14-3-113 · doi:10.1186/2047-783x-14-3-113
- Heeschen, 2004, . Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease., Circulation, 109, 1615, 10.1161/01.CIR.0000124476.32871.E3 · DOI · Paper page
- Junhui, 2008, . Reduced number and activity of circulating endothelial progenitor cells in patients with idiopathic pulmonary arterial hypertension., Respir Med, 102, 1073, 10.1016/j.rmed.2007.12.030 · DOI
- Heringer-Walther, 2009, . Angiotensin-(1-7) stimulates hematopoietic progenitor cells in vitro and in vivo., Haematologica, 94, 857, 10.3324/haematol.2008.000034 · DOI
- Qi, 2013, . Diminazene aceturate enhances angiotensin-converting enzyme 2 activity and attenuates ischemia-induced cardiac pathophysiology., Hypertension, 62, 746, 10.1161/HYPERTENSIONAHA.113.01337 · DOI · Paper page
- Shenoy, 2013, . Diminazene attenuates pulmonary hypertension and improves angiogenic progenitor cell functions in experimental models., Am J Respir Crit Care Med, 187, 648, 10.1164/rccm.201205-0880OC · DOI · Paper page
- He, 2014, . Mesenchymal stem cells overexpressing angiotensin-converting enzyme 2 rescue lipopolysaccharide-induced lung injury., Cell Transplant, 24, 1699, 10.3727/096368914X685087 · DOI · Paper page
- Liu, 2014, . The functional study of human umbilical cord mesenchymal stem cells harbouring angiotensin-converting enzyme 2 in rat acute lung ischemia-reperfusion injury model., Cell Biochem Funct, 32, 580, 10.1002/cbf.3054 · doi:10.1002/cbf.3054
- Imai, 2008, The discovery of angiotensin-converting enzyme 2 and its role in acute lung injury in mice., Exp Physiol, 93, 543, 10.1113/expphysiol.2007.040048 · DOI · Paper page
- Zou, 2014, . Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections., Nat Commun, 5, 3594, 10.1038/ncomms4594 · DOI · Paper page
- Liu, 2014, . Downregulation of angiotensin-converting enzyme 2 by the neuraminidase protein of influenza A (H1N1) virus., Virus Res, 185, 64, 10.1016/j.virusres.2014.03.010 · DOI
- Li, 2013, . ACE2 activation confers endothelial protection and attenuates neointimal lesions in prevention of severe pulmonary arterial hypertension in rats., Lung, 191, 327, 10.1007/s00408-013-9470-8 · DOI
- Yuan, 2015, . Activation of renin-angiotensin-aldosterone system (RAAS) in the lung of smoking-induced pulmonary arterial hypertension (PAH) rats., J Renin Angiotensin Aldosterone Syst, 16, 249, 10.1177/1470320315576256 · DOI
- Shenoy, 2014, . Oral delivery of angiotensin-converting enzyme 2 and angiotensin-(1-7) bioencapsulated in plant cells attenuates pulmonary hypertension., Hypertension, 64, 1248, 10.1161/HYPERTENSIONAHA.114.03871 · DOI · Paper page
- Dai, 2013, . The changes of serum angiotensin-converting enzyme 2 in patients with pulmonary arterial hypertension due to congenital heart disease., Cardiology, 124, 208, 10.1159/000346884 · doi:10.1159/000346884
- Dai, 2014, . Decreased levels of serum angiotensin-(1-7) in patients with pulmonary arterial hypertension due to congenital heart disease., Int J Cardiol, 176, 1399, 10.1016/j.ijcard.2014.08.021 · DOI
- Takahashi, 2010, . Autoantibodies to angiotensin-converting enzyme 2 in patients with connective tissue diseases., Arthritis Res Ther, 12, R85, 10.1186/ar3012 · doi:10.1186/ar3012
- Yamazato, 2009, . Prevention of pulmonary hypertension by angiotensin-converting enzyme 2 gene transfer., Hypertension, 54, 365, 10.1161/HYPERTENSIONAHA.108.125468 · DOI
- Kleinsasser, 2012, . Recombinant angiotensin-converting enzyme 2 suppresses pulmonary vasoconstriction in acute hypoxia., Wilderness Environ Med, 23, 24, 10.1016/j.wem.2011.09.002 · DOI
- Li, 2008, . Angiotensin converting enzyme-2 is protective but downregulated in human and experimental lung fibrosis., Am J Physiol Lung Cell Mol Physiol, 295, L178, 10.1152/ajplung.00009.2008 · DOI · Paper page
- Rey-Parra, 2012, . Angiotensin converting enzyme 2 abrogates bleomycin-induced lung injury., J Mol Med (Berl), 90, 637, 10.1007/s00109-012-0859-2 · DOI · Paper page
- Zhang, 2001, . Collectrin, a collecting duct-specific transmembrane glycoprotein, is a novel homolog of ACE2 and is developmentally regulated in embryonic kidneys., J Biol Chem, 276, 17132, 10.1074/jbc.M006723200 · DOI · Paper page
- Danilczyk, 2006, . Essential role for collectrin in renal amino acid transport., Nature, 444, 1088, 10.1038/nature05475 · DOI · Paper page
- Camargo, 2009, . Tissue-specific amino acid transporter partners ACE2 and collectrin differentially interact with hartnup mutations., Gastroenterology, 136, 872, 10.1053/j.gastro.2008.10.055 · DOI · Paper page
- Kowalczuk, 2008, . A protein complex in the brush-border membrane explains a hartnup disorder allele., FASEB J, 22, 2880, 10.1096/fj.08-107300 · DOI · Paper page
- Murr, 2015, . Low serum tryptophan predicts higher mortality in cardiovascular disease., Eur J Clin Invest, 45, 247, 10.1111/eci.12402 · DOI · Paper page
- Karapetyan, 2013, . Bioactive lipids and cationic antimicrobial peptides as new potential regulators for trafficking of bone marrow-derived stem cells in patients with acute myocardial infarction., Stem Cells Dev, 22, 1645, 10.1089/scd.2012.0488 · DOI
- Korthuis, 1999, . PR-39, a prolinearginine-rich antimicrobial peptide, prevents postischemic microvascular dysfunction., Am J Physiol, 277, H1007
- Ikeda, 2001, . PR-39, a prolinearginine-rich antimicrobial peptide, exerts cardioprotective effects in myocardial ischemia-reperfusion., Cardiovasc Res, 49, 69, 10.1016/S0008-6363(00)00226-1 · DOI · Paper page
- Higazi, 1997, . Defensin stimulates the binding of lipoprotein (a) to human vascular endothelial and smooth muscle cells., Blood, 89, 4290, 10.1182/blood.V89.12.4290 · DOI
- Higazi, 2000, . The alpha-defensins stimulate proteoglycan-dependent catabolism of low-density lipoprotein by vascular cells: a new class of inflammatory apolipoprotein and a possible contributor to atherogenesis., Blood, 96, 1393
- Kougias, 2005, . Defensins and cathelicidins: neutrophil peptides with roles in inflammation, hyperlipidemia and atherosclerosis., J Cell Mol Med, 9, 3, 10.1111/j.1582-4934.2005.tb00332.x · DOI · Paper page
- Zhao, 2012, . Acute ST-segment elevation myocardial infarction is associated with decreased human antimicrobial peptide LL-37 and increased human neutrophil peptide-1 to 3 in plasma., J Atheroscler Thromb, 19, 357, 10.5551/jat.10108 · DOI
- Edfeldt, 2006, . Involvement of the antimicrobial peptide LL-37 in human atherosclerosis., Arterioscler Thromb Vasc Biol, 26, 1551, 10.1161/01.ATV.0000223901.08459.57 · DOI
- Galassi, 2006, Metabolic syndrome and risk of cardiovascular disease: a meta-analysis., Am J Med, 119, 812, 10.1016/j.amjmed.2006.02.031 · DOI · Paper page
- Agerholm-Larsen, 2000, . Effect of 8 week intake of probiotic milk products on risk factors for cardiovascular diseases., Eur J Clin Nutr, 54, 288, 10.1038/sj.ejcn.1600937 · DOI · Paper page
- Kawase, 2000, . Effect of administration of fermented milk containing whey protein concentrate to rats and healthy men on serum lipids and blood pressure., J Dairy Sci, 83, 255, 10.3168/jds.S0022-0302(00)74872-7 · DOI · Paper page
- Naruszewicz, 2002, . Effect of lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers., Am J Clin Nutr, 76, 1249, 10.1093/ajcn/76.6.1249 · DOI · Paper page
- Seppo, 2003, . A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects., Am J Clin Nutr, 77, 326, 10.1093/ajcn/77.2.326 · DOI · Paper page
- Aihara, 2005, . Effect of powdered fermented milk with lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension., J Am Coll Nutr, 24, 257, 10.1080/07315724.2005.10719473 · DOI · Paper page
- Chen, 2014, . Angiotensin-converting enzyme inhibitory activity of lactobacillus helveticus strains from traditional fermented dairy foods and antihypertensive effect of fermented milk of strain H9., J Dairy Sci, 97, 6680, 10.3168/jds.2014-7962 · DOI
- Lin, 1999, Reactive oxygen species and lipid peroxidation product-scavenging ability of yogurt organisms., J Dairy Sci, 82, 1629, 10.3168/jds.S0022-0302(99)75391-9 · DOI · Paper page
- Lin, 2000, Antioxidative effect of intestinal bacteria bifidobacterium longum ATCC 15708 and lactobacillus acidophilus ATCC 4356., Dig Dis Sci, 45, 1617, 10.1023/A:1005577330695 · DOI · Paper page
- Kullisaar, 2002, . Two antioxidative lactobacilli strains as promising probiotics., Int J Food Microbiol, 72, 215, 10.1016/S0168-1605(01)00674-2 · DOI · Paper page
- Kullisaar, 2003, . Antioxidative probiotic fermented goats milk decreases oxidative stress-mediated atherogenicity in human subjects., Br J Nutr, 90, 449, 10.1079/BJN2003896 · DOI · Paper page
- Songisepp, 2005, . Evaluation of the functional efficacy of an antioxidative probiotic in healthy volunteers., Nutr J, 4, 22, 10.1186/1475-2891-4-22 · DOI · Paper page
- Wang, 2006, Antioxidative activities of soymilk fermented with lactic acid bacteria and bifidobacteria., Food Microbiol, 23, 128, 10.1016/j.fm.2005.01.020 · DOI · Paper page
- Jarvenpaa, 2007, . A probiotic, lactobacillus fermentum ME-3, has antioxidative capacity in soft cheese spreads with different fats., J Dairy Sci, 90, 3171, 10.3168/jds.2006-810 · DOI
- Mikelsaar, 2009, Lactobacillus fermentum ME-3-an antimicrobial and antioxidative probiotic., Microb Ecol Health Dis, 21, 1
- Agerholm-Larsen, 2000, . The effect of a probiotic milk product on plasma cholesterol: a meta-analysis of short-term intervention studies., Eur J Clin Nutr, 54, 856, 10.1038/sj.ejcn.1601104 · DOI · Paper page
- Ramchandran, 2008, Proteolytic profiles and angiotensin-I converting enzyme and alpha-glucosidase inhibitory activities of selected lactic acid bacteria., J Food Sci, 73, M75, 10.1111/j.1750-3841.2007.00643.x · DOI
- Ellis, 2013, . Probiotic administration in congenital heart disease: a pilot study., J Perinatol, 33, 691, 10.1038/jp.2013.41 · DOI
- Han, 2014, . Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study., Lancet Respir Med, 2, 548, 10.1016/S2213-2600(14)70069-4 · DOI · Paper page
- Wang, 2013, . Gut-lung crosstalk in pulmonary involvement with inflammatory bowel diseases., World J Gastroenterol, 19, 6794, 10.3748/wjg.v19.i40.6794 · DOI
- Madan, 2012, . Serial analysis of the gut and respiratory microbiome in cystic fibrosis in infancy: Interaction between intestinal and respiratory tracts and impact of nutritional exposures., MBio, 3, e00251, 10.1128/mBio.00251-12 · DOI · Paper page
- Popova, 2012, . Beneficial effects of probiotics in upper respiratory tract infections and their mechanical actions to antagonize pathogens., J Appl Microbiol, 113, 1305, 10.1111/j.1365-2672.2012.05394.x · DOI
- Ferreira, 2010, . Therapeutic implications of the vasoprotective axis of the renin-angiotensin system in cardiovascular diseases., Hypertension, 55, 207, 10.1161/HYPERTENSIONAHA.109.140145 · DOI · Paper page
- Haschke, 2013, . Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects., Clin Pharmacokinet, 52, 783, 10.1007/s40262-013-0072-7 · DOI · Paper page
- Kulemina, 2011, Prediction of off-target effects on angiotensin-converting enzyme 2., J Biomol Screen, 16, 878, 10.1177/1087057111413919 · DOI · Paper page
- Ferreira, 2009, . Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension., Am J Respir Crit Care Med, 179, 1048, 10.1164/rccm.200811-1678OC · DOI · Paper page
- Li, 2012, . Angiotensin-converting enzyme 2 activation protects against pulmonary arterial hypertension through improving early endothelial function and mediating cytokines levels., Chin Med J (Engl), 125, 1381
- Peregrine, 1993, Pharmacology of diminazene: a review., Acta Trop, 54, 185, 10.1016/0001-706X(93)90092-P · DOI · Paper page
- Haber, 2014, . Angiotensin-converting enzyme 2-independent action of presumed angiotensin-converting enzyme 2 activators: studies in vivo, ex vivo, and in vitro., Hypertension, 63, 774, 10.1161/HYPERTENSIONAHA.113.02856 · DOI · Paper page
- Velkoska, 2015, . Short-term treatment with diminazene aceturate ameliorates the reduction in kidney ACE2 activity in rats with subtotal nephrectomy., PLoS One, 10, e0118758, 10.1371/journal.pone.0118758 · doi:10.1371/journal.pone.0118758
- Fraga-Silva, 2013, . Angiotensin-converting enzyme 2 activation improves endothelial function., Hypertension, 61, 1233, 10.1161/HYPERTENSIONAHA.111.00627 · DOI · Paper page
- Fraga-Silva, 2010, . ACE2 activation promotes antithrombotic activity., Mol Med, 16, 210, 10.2119/molmed.2009.00160 · DOI · Paper page
- Ferreira, 2011, . Angiotensin-converting enzyme 2 activation protects against hypertension-induced cardiac fibrosis involving extracellular signal-regulated kinases., Exp Physiol, 96, 287, 10.1113/expphysiol.2010.055277 · DOI · Paper page
- Qiu, 2014, . Angiotensin-converting enzyme 2 (ACE2) activator diminazene aceturate ameliorates endotoxin-induced uveitis in mice., Invest Ophthalmol Vis Sci, 55, 3809, 10.1167/iovs.14-13883 · DOI · Paper page
- Thatcher, 2014, . Angiotensin-converting enzyme 2 decreases formation and severity of angiotensin II-induced abdominal aortic aneurysms., Arterioscler Thromb Vasc Biol, 34, 2617, 10.1161/ATVBAHA.114.304613 · DOI
- Mecca, 2011, . Cerebroprotection by angiotensin-(1-7) in endothelin-1-induced ischaemic stroke., Exp Physiol, 96, 1084, 10.1113/expphysiol.2011.058578 · DOI · Paper page
- Haga, 2015, . A novel ACE2 activator reduces monocrotaline-induced pulmonary hypertension by suppressing the JAKSTAT and TGF-beta cascades with restored caveolin-1 expression., Exp Lung Res, 41, 21, 10.3109/01902148.2014.959141 · DOI
- Kirkpatrick, 2012, Assessment of ventricular remodeling in heart failure clinical trials., Curr Heart Fail Rep, 9, 328, 10.1007/s11897-012-0116-6 · DOI
- Bleumink, 2004, . Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure the rotterdam study., Eur Heart J, 25, 1614, 10.1016/j.ehj.2004.06.038 · DOI
- Min, 2015, . Therapeutic effect of human umbilical cord mesenchymal stem cells modified by angiotensin-converting enzyme 2 gene on bleomycin-induced lung fibrosis injury., Mol Med Rep, 11, 2387, 10.3892/mmr.2014.3025 · DOI
- Ruf, 2007, Determining the transgene containment level provided by chloroplast transformation., Proc Natl Acad Sci U S A, 104, 6998, 10.1073/pnas.0700008104 · DOI · Paper page
- Scotti, 2012, Plastid transformation as an expression tool for plant-derived biopharmaceuticals., Methods Mol Biol, 847, 451, 10.1007/978-1-61779-558-9_35 · doi:10.1007/978-1-61779-558-9_35
Cited by
Gheblawi, M., Wang, K., Viveiros, A., Nguyen, Q., Zhong, J.-C., Turner, A. J., Raizada, M. K., Grant, M. B., & Oudit, G. Y. (2020) · Circulation Research · doi:10.1161/circresaha.120.317015 · Cited by 1,882
Self-citationAlterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 Influenza
Gu, S., Chen, Y., Wu, Z., Chen, Y., Gao, H., Lv, L., Guo, F., Zhang, X., Luo, R., Huang, C., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa709 · Cited by 788
Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome
Villapol, S. (2020) · Translational Research · doi:10.1016/j.trsl.2020.08.004 · Cited by 343
Body Localization of ACE-2: On the Trail of the Keyhole of SARS-CoV-2
Salamanna, F., Maglio, M., Landini, M. P., & Fini, M. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.594495 · Cited by 281
Li, Q., Cheng, F., Xu, Q., Su, Y., Cai, X., Zeng, F., & Zhang, Y. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107531 · Cited by 64
Metadata
- Authors
- Cole-Jeffrey, C. T., Liu, M., Katovich, M. J., Raizada, M. K., & Shenoy, V.
- Venue
- Journal of Cardiovascular Pharmacology
- Published
- 2015-12
- Volume
- 66
- Issue
- 6
- Pages
- 540-550
- ISSN
- 0160-2446 (ISSN-L)
- OpenAlex
- W2411625446
- Cited by
- 103
- References
- 24
- FWCI
- 1.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: ACE2 and Microbiota: Emerging Targets for Cardiopulmonary Disease Therapy. https://app.cochat.ai/papers/10.1097/fjc.0000000000000307
- The paper
- Cole-Jeffrey, C. T., Liu, M., Katovich, M. J., Raizada, M. K., & Shenoy, V. (2015). ACE2 and Microbiota: Emerging Targets for Cardiopulmonary Disease Therapy. Journal of Cardiovascular Pharmacology. https://doi.org/10.1097/fjc.0000000000000307
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.